Daniel Da Costa

1.2k total citations
24 papers, 314 citations indexed

About

Daniel Da Costa is a scholar working on Oncology, Epidemiology and Neurology. According to data from OpenAlex, Daniel Da Costa has authored 24 papers receiving a total of 314 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 5 papers in Epidemiology and 4 papers in Neurology. Recurrent topics in Daniel Da Costa's work include Glioma Diagnosis and Treatment (3 papers), Neuroblastoma Research and Treatments (3 papers) and Lung Cancer Research Studies (3 papers). Daniel Da Costa is often cited by papers focused on Glioma Diagnosis and Treatment (3 papers), Neuroblastoma Research and Treatments (3 papers) and Lung Cancer Research Studies (3 papers). Daniel Da Costa collaborates with scholars based in Canada, United States and United Kingdom. Daniel Da Costa's co-authors include Mirjam B. Zeisel, Sébastien Pfeffer, Erika Girardi, Thomas F. Baumert, Marine Turek, Gang Long, Daniel J. Felmlee, Ralf Bartenschlager, R. C. Noble and Neil R. Cameron and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Virology and Annals of Oncology.

In The Last Decade

Daniel Da Costa

24 papers receiving 300 citations

Peers

Countries citing papers authored by Daniel Da Costa

Since Specialization

Citations

This map shows the geographic impact of Daniel Da Costa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Da Costa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Da Costa more than expected).

Fields of papers citing papers by Daniel Da Costa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Da Costa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Da Costa. The network helps show where Daniel Da Costa may publish in the future.

Co-authorship network of co-authors of Daniel Da Costa

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Da Costa. A scholar is included among the top collaborators of Daniel Da Costa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Da Costa. Daniel Da Costa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Newly Qualified Canadian Nurses’ Experiences With Digital Health in the Workplace: Comparative Qualitative Analysis 2024 ·JMIR Medical Education ·Manal Kleib, Antonia Arnaert, Lynn Nagle, (unknown), Daniel Da Costa	2
2	Digital Health Education and Training for Undergraduate and Graduate Nursing Students: Scoping Review 2024 ·PubMed ·Manal Kleib, Antonia Arnaert, Lynn Nagle, (unknown), (unknown), Daniel Da Costa, Megan Kennedy, (unknown)	11
3	Resources to Support Canadian Nurses to Deliver Virtual Care: Environmental Scan 2024 ·JMIR Medical Education ·Manal Kleib, Antonia Arnaert, Lynn Nagle, (unknown), (unknown), Daniel Da Costa, (unknown)	1
4	Acceptance of the Apple Watch Series 6 for Telemonitoring of Older Adults With Chronic Obstructive Pulmonary Disease: Qualitative Descriptive Study Part 1 2023 ·JMIR Aging ·Antonia Arnaert, (unknown), Daniel Da Costa, (unknown), (unknown), S. Charbonneau	8
5	Experiences of Patients With Chronic Obstructive Pulmonary Disease Using the Apple Watch Series 6 Versus the Traditional Finger Pulse Oximeter for Home SpO2 Self-Monitoring: Qualitative Study Part 2 2023 ·JMIR Aging ·(unknown), Antonia Arnaert, Daniel Da Costa, (unknown), (unknown), S. Charbonneau	1
6	LGG-09. CLINICAL ACTIVITY OF PAN-RAF INHIBITOR TOVORAFENIB IN THE REGISTRATIONAL PEDIATRIC LOW-GRADE GLIOMA ARM OF THE PHASE 2 FIREFLY-1 (PNOC026) STUDY 2023 ·Neuro-Oncology ·Lindsay Kilburn, Dong‐Anh Khuong‐Quang, Karsten Nysom, Daniel Landi, David S. Ziegler, Pablo Hernáiz Driever, Sarah Leary, Simon Bailey, Jasper van der Lugt, Sébastien Perreault, Angela J. Waanders, Patricia Baxter, Olaf Witt, Darren Hargrave, Geoffrey McCowage, (unknown), Daniel Da Costa, Michael C. Cox, Peter Manley, Jordan R. Hansford	1
7	Clinical activity of pan-RAF inhibitor tovorafenib in the registrational pediatric low-grade glioma arm of the phase 2 FIREFLY-1 (PNOC026) study. 2023 ·Journal of Clinical Oncology ·Lindsay Kilburn, Dong‐Anh Khuong‐Quang, Karsten Nysom, Daniel Landi, David S. Ziegler, Pablo Hernáiz Driever, Sarah Leary, Simon Bailey, Jasper van der Lugt, Sébastien Perreault, Angela J. Waanders, Patricia Baxter, Olaf Witt, Darren Hargrave, Geoffrey McCowage, (unknown), Daniel Da Costa, Michael C. Cox, Peter Manley, Jordan R. Hansford	5
8	FIREFLY-1 (PNOC 026): A phase 2 study to evaluate the safety and efficacy of tovorafenib (DAY101) in pediatric patients with RAF-altered recurrent or progressive low-grade glioma or advanced solid tumors. 2022 ·Journal of Clinical Oncology ·Daniel Landi, David S. Ziegler, (unknown), Patricia Baxter, Sarah Leary, (unknown), Angela J. Waanders, Jasper van der Lugt, Geoffrey McCowage, François Doz, Nada Jabado, Elisabetta Schiavello, Michal Zápotocký, (unknown), Samuel C. Blackman, Daniel Da Costa, Michael C. Cox, Olaf Witt, Lindsay Kilburn, Jordan R. Hansford	3
9	975TiP Phase Ib trial of ABBV-368 + tilsotolimod in combination with nab-paclitaxel and/or budigalimab (ABBV-181) in patients with recurrent/metastatic head and neck squamous cell carcinoma 2020 ·Annals of Oncology ·Xiuning Le, (unknown), Corinne Maurice‐Dror, Aru Panwar, Kathryn A. Gold, Jordan Berlin, Tingjun Dai, Jaspreet Singh Grewal, Misako Nagasaka, Ari J. Rosenberg, Missak Haigentz, Christophe Le Tourneau, (unknown), Michael A. McDevitt, Maulik Patel, Daniel Da Costa, Stacie Lambert, (unknown), Martha Blaney, Maura L. Gillison	3
10	Effects of Rovalpituzumab Tesirine on Ventricular Repolarization in Patients With Small‐Cell Lung Cancer 2020 ·Clinical and Translational Science ·Jonathan W. Goldman, Minal Barve, Jyoti D. Patel, Antoinette J. Wozniak, Afshin Dowlati, Alexander Starodub, Taofeek K. Owonikoko, William J. Edenfield, Scott A. Laurie, Daniel Da Costa, Satwant Lally, (unknown), Matthew P. Kosloski, David Hoffman, Grace K. Dy	5
11	A single-center, open-label study investigating the excretion balance, pharmacokinetics, metabolism, and absolute bioavailability of a single oral dose of [14C]-labeled idasanutlin and an intravenous tracer dose of [13C]-labeled idasanutlin in a single cohort of patients with solid tumors 2019 ·Cancer Chemotherapy and Pharmacology ·Zsuzsanna Pápai, Lin-Chi Chen, Daniel Da Costa, Steven Blotner, Faye Vazvaei, (unknown), Russell G. Jones, Jianguo Zhi	14
12	Disminución en la frecuencia de infección por Helicobacter pylori en endoscopías digestivas altas 2018 ·Revista médica de Chile ·Daniel Da Costa, Francesca Guidotti, (unknown), Francisco J. Trigo‐Tavera, (unknown), (unknown), (unknown), (unknown), (unknown), Zoltán Berger	6
13	Escleroterapia endoscópica asistida mediante balón oclusivo como tratamiento de varices gástricas cardiofúndicas de alto riesgo: Reporte de dos casos y revisión de la literatura 2017 ·Revista médica de Chile ·Daniel Da Costa, (unknown), (unknown), Germán Lobos, (unknown), Jaime Poníachik	1
14	Dissociation of Survival, Proliferation, and State Control in Human Hematopoietic Stem Cells 2017 ·Stem Cell Reports ·David J. H. F. Knapp, Colin A. Hammond, Paul H. Miller, (unknown), Philip Beer, Markéta Řičicová, (unknown), Daniel Da Costa, Michael VanInsberghe, Alice M.S. Cheung, Davide Pellacani, James M. Piret, Carl L. Hansen, Connie J. Eaves	26
15	A study of rovalpituzumab tesirine in frontline treatment of patients with DLL3 expressing extensive small cell lung cancer. 2017 ·Journal of Clinical Oncology ·Christine L. Hann, Daniel Morgensztern, Afshin Dowlati, Timothy F. Burns, Robert M. Jotte, Nathan A. Pennell, Stephen Richey, Juergen Wolf, Martin Sebastian, Tobias R. Overbeck, Mark A. Socinski, Satwant Lally, Daniel Da Costa, Sreeni Yalamanchili, D. Ross Camidge	3
16	Novel methods for the synthesis of 1,5,2-diazaphosphinines as potential inhibitors of HCV polymerase 2016 ·Tetrahedron Letters ·Daniel Da Costa, Arlène Roland, Cyril B. Dousson	2
17	Real-Time Quantitative Elasticity Imaging of Deep Tissue Using Free-Hand Conventional Ultrasound 2012 ·Lecture notes in computer science ·(unknown), (unknown), Weiqi Wang, Daniel Da Costa, (unknown), Ramin S. Sahebjavaher, Septimiu E. Salcudean, Robert Rohling	21
18	Spontaneous bilateral internal carotid artery dissection 2009 ·BMJ Case Reports ·(unknown), (unknown), Daniel Da Costa	3
19	A carbohydrate-antioxidant hybrid polymer reduces oxidative damage in spermatozoa and enhances fertility 2005 ·Nature Chemical Biology ·(unknown), A. Maldjian, Daniel Da Costa, (unknown), David M. Haddleton, Justin C. St. John, P.C. Penny, R. C. Noble, Neil R. Cameron, Benjamin G. Davis	55
20	Drug points: Generalised pruritus associated with amlodipine 1997 ·BMJ ·Steve Orme, Daniel Da Costa	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact